Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study.

Saved in:
Bibliographic Details
Title: Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study.
Authors: Wiegmann JP; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany., Fröhlich T; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany., Möhn N; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany.; Department of Neurology, Hannover Medical School, Hannover, Germany., Duzzi L; Department of Neurology, Hannover Medical School, Hannover, Germany., Narten E; Department of Neurology, Hannover Medical School, Hannover, Germany., Aurich J; Department of Neurology, Hannover Medical School, Hannover, Germany., Thomas J; Department of Neurology, Hannover Medical School, Hannover, Germany., Grote-Levi L; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany.; Department of Neurology, Hannover Medical School, Hannover, Germany., Mahjoub S; Department of Neurology, Hannover Medical School, Hannover, Germany., Berliner D; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany.; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany., Wirth T; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany.; Department of Gastroenterology, Hepatology, Infectious Disease and Endocrinology, Hannover Medical School, Hannover, Germany., Golpon H; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany.; Department of Respiratory Medicine and Infectious Disease, Hannover Medical School, Hannover, Germany., Bollmann BA; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany.; Department of Respiratory Medicine and Infectious Disease, Hannover Medical School, Hannover, Germany., Von Wasilewski I; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany.; Department of Dermatology, Allergology and Venerology, Hannover Medical School, Hannover, Germany., Gutzmer R; Department of Dermatology, Johannes Wesling Medical Centre, Minden, Germany., Heidel FH; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany., Skripuletz T; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany.; Department of Neurology, Hannover Medical School, Hannover, Germany., Beutel G; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany., Ivanyi P; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; ICOG-CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover), Hannover, Germany.; Interdisziplinäre Arbeitsgruppe Nierenzellkarzinom IAG-N, Deutsche Krebsgesellschaft, Berlin, Germany.
Corporate Authors: ICOG‐CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover)
Source: Cancer medicine [Cancer Med] 2025 Feb; Vol. 14 (3), pp. e70582.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2045-7634
DOI:10.1002/cam4.70582